B细胞-话题@MedSci

#B细胞#

314篇内容 | 4674人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273200, encodeId=583412e32004d, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Arthritis Rheumatol ：干燥综合征患者缺陷性早期B细胞耐受检查点, objectType=article, longId=105649, objectId=f3b010564957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3b010564957, replyNumber=0, likeNumber=84, createdTime=2017-07-17, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3b010564957, moduleTitle=Arthritis Rheumatol ：干燥综合征患者缺陷性早期B细胞耐受检查点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3b010564957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273199, encodeId=39d412e31999a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Ann Rheum Dis：系统性红斑狼疮中使用B细胞生物标记物预测和管理利妥昔单抗无应答, objectType=article, longId=104914, objectId=fd371049147b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd371049147b, replyNumber=0, likeNumber=83, createdTime=2017-07-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd371049147b, moduleTitle=Ann Rheum Dis：系统性红斑狼疮中使用B细胞生物标记物预测和管理利妥昔单抗无应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd371049147b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273198, encodeId=a01612e319892, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, objectType=article, longId=104214, objectId=35571042148f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35571042148f, replyNumber=0, likeNumber=58, createdTime=2017-07-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35571042148f, moduleTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35571042148f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273197, encodeId=46e812e319798, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究, objectType=article, longId=103953, objectId=9e52103953a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e52103953a4, replyNumber=0, likeNumber=64, createdTime=2017-07-01, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e52103953a4, moduleTitle=Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e52103953a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273196, encodeId=18e212e3196cf, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤的tonic BCR信号通路。, objectType=article, longId=103296, objectId=e8f51032963e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8f51032963e, replyNumber=0, likeNumber=72, createdTime=2017-06-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8f51032963e, moduleTitle=Blood：弥漫性大B细胞淋巴瘤的tonic BCR信号通路。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8f51032963e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273195, encodeId=6fde12e31956a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=EMB0 J：研究发现胰岛B细胞的“防护罩”，糖尿病治疗出现新选择！, objectType=article, longId=102958, objectId=f187102958c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f187102958c1, replyNumber=0, likeNumber=63, createdTime=2017-06-24, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f187102958c1, moduleTitle=EMB0 J：研究发现胰岛B细胞的“防护罩”，糖尿病治疗出现新选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f187102958c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273194, encodeId=130b12e3194b3, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nature Medicine：脾脏边缘区域B细胞识别胆固醇抑制动脉粥状硬化, objectType=article, longId=98079, objectId=d0cf980e966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0cf980e966, replyNumber=0, likeNumber=81, createdTime=2017-05-08, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0cf980e966, moduleTitle=Nature Medicine：脾脏边缘区域B细胞识别胆固醇抑制动脉粥状硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0cf980e966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273193, encodeId=54b212e319335, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Leuk Lymphoma：体重指数可以预测弥漫性大B细胞淋巴瘤的结局吗？, objectType=article, longId=97762, objectId=904e9e7626b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=904e9e7626b, replyNumber=0, likeNumber=67, createdTime=2017-05-04, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=904e9e7626b, moduleTitle=Leuk Lymphoma：体重指数可以预测弥漫性大B细胞淋巴瘤的结局吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=904e9e7626b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273192, encodeId=f23112e3192d2, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Sci Rep：过敏性疾病机理研究：免疫球蛋白E可不对称的结合到B细胞受体CD23, objectType=article, longId=97409, objectId=3eae9e40971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eae9e40971, replyNumber=0, likeNumber=94, createdTime=2017-04-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eae9e40971, moduleTitle=Sci Rep：过敏性疾病机理研究：免疫球蛋白E可不对称的结合到B细胞受体CD23, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eae9e40971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273191, encodeId=1b6d12e31916f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=PNAS：EBV如何促使B细胞癌变，产生淋巴癌, objectType=article, longId=97297, objectId=c5e19e2978b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5e19e2978b, replyNumber=0, likeNumber=66, createdTime=2017-04-28, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5e19e2978b, moduleTitle=PNAS：EBV如何促使B细胞癌变，产生淋巴癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5e19e2978b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273190, encodeId=fe3112e31903b, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nature Medicine：边缘区B细胞控制滤泡辅助性T细胞对高胆固醇饮食的反应！, objectType=article, longId=96209, objectId=d80f9620979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d80f9620979, replyNumber=0, likeNumber=73, createdTime=2017-04-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d80f9620979, moduleTitle=Nature Medicine：边缘区B细胞控制滤泡辅助性T细胞对高胆固醇饮食的反应！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d80f9620979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273189, encodeId=01d012e318936, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NT J LAB HEMATOL：B细胞淋巴增生性疾病进行诊断的成本效益新方法, objectType=article, longId=95816, objectId=2b6b95816d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b6b95816d8, replyNumber=0, likeNumber=51, createdTime=2017-04-17, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b6b95816d8, moduleTitle=NT J LAB HEMATOL：B细胞淋巴增生性疾病进行诊断的成本效益新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b6b95816d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273188, encodeId=a23312e3188a5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Crit Care Med：脓毒症患者记忆B细胞会出现活化相关的加速凋亡！, objectType=article, longId=92842, objectId=ae0c92842c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae0c92842c7, replyNumber=0, likeNumber=68, createdTime=2017-03-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae0c92842c7, moduleTitle=Crit Care Med：脓毒症患者记忆B细胞会出现活化相关的加速凋亡！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae0c92842c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273187, encodeId=137a12e31879f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：治疗白血病和骨髓瘤的新免疫疗法：人工在T细胞表达受体识别B细胞转录因子BOB1阳性的血癌细胞, objectType=article, longId=91763, objectId=e4bc91e630c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4bc91e630c, replyNumber=0, likeNumber=61, createdTime=2017-03-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4bc91e630c, moduleTitle=Blood：治疗白血病和骨髓瘤的新免疫疗法：人工在T细胞表达受体识别B细胞转录因子BOB1阳性的血癌细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4bc91e630c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273186, encodeId=9e0612e3186d9, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=J CLIN INVEST：T-bet+ B细胞导致系统性红斑狼疮等自体免疫疾病, objectType=article, longId=91675, objectId=6291916e54b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6291916e54b, replyNumber=0, likeNumber=63, createdTime=2017-03-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6291916e54b, moduleTitle=J CLIN INVEST：T-bet+ B细胞导致系统性红斑狼疮等自体免疫疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6291916e54b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273185, encodeId=ded812e318531, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=[ASH 2016]B细胞淋巴瘤临床研究进展, objectType=article, longId=88910, objectId=36948891040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36948891040, replyNumber=0, likeNumber=71, createdTime=2017-02-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36948891040, moduleTitle=[ASH 2016]B细胞淋巴瘤临床研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36948891040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273184, encodeId=78ac12e3184e9, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, objectType=article, longId=88127, objectId=d4478812e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4478812e0b, replyNumber=0, likeNumber=52, createdTime=2017-01-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4478812e0b, moduleTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4478812e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273183, encodeId=8d8e12e318354, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：PIKfyve激酶抑制剂-阿匹莫德（apilimod）作为治疗B细胞非霍奇金淋巴瘤的鉴定, objectType=article, longId=88077, objectId=d1a0880e7c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1a0880e7c8, replyNumber=0, likeNumber=68, createdTime=2017-01-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1a0880e7c8, moduleTitle=Blood：PIKfyve激酶抑制剂-阿匹莫德（apilimod）作为治疗B细胞非霍奇金淋巴瘤的鉴定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1a0880e7c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273182, encodeId=fb2312e3182ef, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=TREAKISYM获批成为低度B细胞非霍奇金淋巴瘤和套细胞淋巴瘤抗癌剂, objectType=article, longId=87833, objectId=1fe48e83325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe48e83325, replyNumber=0, likeNumber=81, createdTime=2017-01-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe48e83325, moduleTitle=TREAKISYM获批成为低度B细胞非霍奇金淋巴瘤和套细胞淋巴瘤抗癌剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe48e83325)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273181, encodeId=1aa112e31819a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Human Gene Therapy：非病毒基因载体技术治疗B细胞淋巴瘤研究进展, objectType=article, longId=85798, objectId=9f9f85e98e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f9f85e98e9, replyNumber=0, likeNumber=59, createdTime=2016-12-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f9f85e98e9, moduleTitle=Human Gene Therapy：非病毒基因载体技术治疗B细胞淋巴瘤研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f9f85e98e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Arthritis Rheumatol ：干燥综合征患者缺陷性早期B细胞耐受检查点

2017-07-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Ann Rheum Dis：系统性红斑狼疮中使用B细胞生物标记物预测和管理利妥昔单抗无应答

2017-07-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！

2017-07-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究

2017-07-01

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：弥漫性大B细胞淋巴瘤的tonic BCR信号通路。

2017-06-26

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

EMB0 J：研究发现胰岛B细胞的“防护罩”，糖尿病治疗出现新选择！

2017-06-24

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Nature Medicine：脾脏边缘区域B细胞识别胆固醇抑制动脉粥状硬化

2017-05-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Leuk Lymphoma：体重指数可以预测弥漫性大B细胞淋巴瘤的结局吗？

2017-05-04

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Sci Rep：过敏性疾病机理研究：免疫球蛋白E可不对称的结合到B细胞受体CD23

2017-04-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

PNAS：EBV如何促使B细胞癌变，产生淋巴癌

2017-04-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Nature Medicine：边缘区B细胞控制滤泡辅助性T细胞对高胆固醇饮食的反应！

2017-04-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NT J LAB HEMATOL：B细胞淋巴增生性疾病进行诊断的成本效益新方法

2017-04-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Crit Care Med：脓毒症患者记忆B细胞会出现活化相关的加速凋亡！

2017-03-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：治疗白血病和骨髓瘤的新免疫疗法：人工在T细胞表达受体识别B细胞转录因子BOB1阳性的血癌细胞

2017-03-16

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

J CLIN INVEST：T-bet+ B细胞导致系统性红斑狼疮等自体免疫疾病

2017-03-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

[ASH 2016]B细胞淋巴瘤临床研究进展

2017-02-16

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病

2017-01-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：PIKfyve激酶抑制剂-阿匹莫德（apilimod）作为治疗B细胞非霍奇金淋巴瘤的鉴定

2017-01-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

TREAKISYM获批成为低度B细胞非霍奇金淋巴瘤和套细胞淋巴瘤抗癌剂

2017-01-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Human Gene Therapy：非病毒基因载体技术治疗B细胞淋巴瘤研究进展

2016-12-29

科室
- - 订阅+
  - 更多科室
工具
服务